Diethylstilbestrol and other nonsteroidal estrogens: Novel class of store-operated calcium channel modulators

Journal of Cardiovascular Pharmacology

Volumn 55, Issue 5, 2010, Pages 522-530

  Dobrydneva, Yuliya ^a   Williams, Roy L ^a   Blackmore, Peter F ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Calcium influx; Diethylstilbestrol; Platelets; Stilbene; Thrombin

Indexed keywords

CALCIUM CHANNEL; CHRYSENE DERIVATIVE; DIETHYLSTILBESTROL; DIHYDROGENISTEIN; EQUOL; ESTROGEN; FLAVANONE DERIVATIVE; FLAVONE DERIVATIVE; FURA 2; GENISTEIN; GLYCOSIDE; HEXESTROL DERIVATIVE; HYDROXYL GROUP; INDENESTROL A; INDENESTROL B; ISOFLAVONE DERIVATIVE; POLYPHENOL DERIVATIVE; RESVERATROL; STILBENE DERIVATIVE; TETRAHYDROCHRYSENE; THROMBIN; UNCLASSIFIED DRUG;

CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIETARY INTAKE; DRUG STRUCTURE; ESTERIFICATION; HUMAN; HUMAN CELL; PHARMACOPHORE; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION; THROMBOCYTE;

BLOOD PLATELETS; CALCIUM; CALCIUM CHANNELS; CELLS, CULTURED; DIETHYLSTILBESTROL; ESTROGENS, NON-STEROIDAL; FURA-2; HUMANS; MOLECULAR STRUCTURE; PLATELET ACTIVATION; STRUCTURE-ACTIVITY RELATIONSHIP; THROMBIN;

EID: 77952991711     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3181d64b33     Document Type: Review

References (44)

1. Meyers MJ, Sun J, Carlson KE, et al. Estrogen receptor-potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem. 2001;44:4230-4251.
2. Dobrydneva Y, Williams RL, Katzenellenbogen JA, et al. Diethylstilbestrol and tetrahydrochrysenes are calcium channel blockers in human platelets: relationship to the stilbene pharmacophore. Thromb Res. 2003;110:23-31.
3. Zakharov SI, Smani T, Dobrydneva Y, et al. Diethylstilbestrol (DES) is a potent inhibitor of CRAC channels and store-operated Ca2+ influx. Mol Pharmacol. 2004;66:702-707.
4. Berridge MJ. Inositol trisphosphate and calcium signalling mechanisms. Biochem Biophys Acta. 2009;1793:933-940.
5. Varnai P, Hunyady L, Balla T. STIM and Orai: the long-awaited constituents of store-operated calcium entry. Trends Pharmacol Sci. 2009;30:118-128.
6. Salido GM, Sage SO, Rosado JA. Biochemical and functional properties of the store-operated Ca2+ channels. Cell Signal. 2009;21:457-461.
7. Putney JW. New molecular players in capacitative Ca2+ entry. J Cell Sci. 2007;120:1959-1965.
8. Sweeney ZK, Minatti A, Button DC, et al. Small-molecule inhibitors of store-operated calcium entry. Chem Med Chem. 2009, 4:706-718.
9. Triplett DA. Coagulation and bleeding disorders: review and update. Clin Chem. 2000;46:1260-1269.
10. Varga-Szabo D, Braun A, Nieswandt B. Calcium signaling in platelets. J Thromb Haemost. 2009;7:1057-1066.
11. Harper MT, Sage SO. PAR-1-dependent pp60src activation is dependent on protein kinase C and increased [Ca2+]i: evidence that pp60src does not regulate PAR-1-dependent Ca2+ entry in human platelets. J Thromb Haemost. 2006;4:2695-2703.
12. Losel R, Wehling M. Nongenomic actions of steroid hormones. Nat Rev Mol Cell Biol. 2003;4:46-56.
13. Dziadek MA, Johnstone LS. Biochemical properties and cellular localization of STIM proteins. Cell Calcium. 2007;42:123-132.
14. Lopez JJ, Salido GM, Pariente JA, et al. Interaction of STIM1 with endogenously expressed human canonical TRP1 upon depletion of intracellular Ca2+ stores. J Biol Chem. 2006;281:28254-28264.
15. Jardin I, Lopez JJ, Salido GM, et al. Orai1 mediates the interaction between STIM1 and hTRPC1 and regulates the mode of activation of hTRPC1-forming Ca2+ channels. J Biol Chem. 2008;283:25296-25304.
16. Tolhurst G, Carter RN, Amisten S, et al. Expression profiling and electrophysiological studies suggest a major role for Orai1 in the storeoperated Ca2+ influx pathway of platelets and megakaryocytes. Platelets. 2008;19:308-313.
17. Braun A, Varga-Szabo D, Kleinschnitz C, et al. Orai1 (CRACM1) is the platelet SOC channel and essential for pathological thrombus formation. Blood. 2009;113:2056-2063.
18. Rosado JA, Sage SO. Coupling between inositol 1, 4, 5-trisphosphate receptors and human transient receptor potential channel 1 when intracellular Ca2+ stores are depleted. Biochem J. 2000;350:631-635.
19. Varga-Szabo D, Authi KS, Braun A, et al. Store-operated Ca2+ entry in platelets occurs independently of transient receptor potential (TRP) C1. Pflugers Arch. 2008;457:377-387.
20. Jardin I, Gomez LJ, Salido GM, et al. Dynamic interaction of hTRPC6 with Orai1/STIM1 complex or hTRPC3 mediates its role in capacitative or non-capacitative Ca2+ entry pathways. Biochem J. 2009;420:267-276.
21. Hassock SR, Zhu MX, Trost C, et al. Expression and role of TRPC proteins in human platelets: evidence that TRPC6 forms the storeindependent calcium entry channel. Blood. 2002;100:2801-2811.
22. Dobrydneva Y, Williams RL, Blackmore PF. trans-Resveratrol inhibits calcium influx in thrombin-stimulated human platelets. Br J Pharmacol. 1999;128:149-157.
23. Dobrydneva Y, Williams R, Morris GZ, et al. Dietary phytoestrogens and their synthetic structural analogs as calcium channel blockers in human platelets. J Cardiovasc Pharmacol. 2002;40:399-410.
24. Dobrydneva Y, Blackmore PF. 2-Aminoethoxydiphenyl borate directly inhibits store-operated calcium entry channels in human platelets. Mol Pharm. 2001;60:541-552.
25. Dobrydenva Y, Abelt CJ, Dovel B, et al. 2-Aminoethoxydiphenyl borate as a prototype drug for a group of structurally related calcium channel blockers in human platelets. Mol Pharm. 2006;69:247-256.
26. Gwozdz T, Dutko-Gwozdz J, Zarayskiy V, et al. How strict is the correlation between STIM1 and Orai1 expression, puncta formation, and I-CRAC activation? Am J Physiol. 2008; 295: C1133-C1140.
27. 2+ entry in vascular smooth muscle cells. J Pharmacol Exp Ther. 2006;317:488-499.
28. 2+ entry in rat microglia. Channels. 2009;3:129-139.
29. Martin-Romero FJ, Ortiz-De-Galisteo LR, Lara-Laranjeira J, et al. Storeoperated calcium entry in human oocytes and sensitivity to oxidative stress. Biol Reprod. 2008;78:307-315.
30. Smani T, Dominguez-Rodriguez A, Hmadcha A, et al. Role of Ca2+-independent phospholipase A (2) and store-operated pathway in urocortininduced vasodilatation of rat coronary artery. Circ Res. 2007;101:1194-1203.
31. Deitch EA, Ananthakrishnan P, Cohen DB, et al. Neutrophil activation is modulated by sex hormones after trauma-hemorrhagic shock and burn injuries. Am J Physiol. 2006; 291: H1456-H1465.
32. Pavani M, Fones E, Oksenberg D, et al. Inhibition of tumoral cell respiration and growth by nordihydroguaiaretic acid. Biochem Pharmacol. 1994;48:1935-1942.
33. Meyers MJ, Sun J, Carlson KE, et al. Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis-and trans-5, 11-dialkyl-5, 6, 11, 12-tetrahydrochrysenes. J Med Chem. 1999;42:2456-2468.
34. Kuiper GGJM, Lemmen JG, Carlsson B, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor b. Endocrinology. 1998;139:4252-4263.
35. Shutt DI, Cox RI. Steroid and phytoestrogen binding to sheep uterine receptors in vitro. J Endocrinol. 1972;52:299-310.
36. Merritt JE, Armstrong WP, Benham CD, et al. SK&F 96365, a novel inhibitor of receptor-mediated calcium entry. Biochem J. 1990;271:515-522.
37. Leung YM, Kwan CY. Current perspectives in the pharmacological studies of store-operated Ca2+ entry blockers. Jpn J Pharmacol. 1999;81:253-258.
38. Tanaka M, Fujimoto K, Chihara Y, et al. Isoflavone supplements stimulated the production of serum equol and decreased the serum dihydrotesterone levels in healthy male volunteers. Prostate Cancer Prostatic Dis. 2009;12:247-252.
39. Jackman KA, Woodman OL, Sobey CG. Isoflavones, equol and cardiovascular disease: pharmacological and therapeutic insights. Curr Med Chem. 2007;14:2824-2830.
40. Cassidy A, Hooper L. Phytoestrogens and cardiovascular disease. J Br Menopause Soc. 2006;12:49-56.
41. Park D, Huang T, Frishman WH. Phytoestrogens as cardioprotective agents. Cardiol Rev. 2005;13:13-17.
42. Carlson S, Peng N, Prasain J, et al. The effects of botanical supplements on cardiovascular, cognitive and metabolic function in males and females. Gen Med. 2008; 5: S76-S90.
43. Lampe JW. Isoflavonoid and lignin phytoestrogens as dietary biomarkers. J Nutr. 2003;133:956S-964S.
44. Cassidy A, Albertazzi P, Nielsen IL, et al. Critical review of health effects of soybean phyto-oestrogens in post-menopausal women. Proc Nutr Soc. 2006;65:76-92.